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Take home message 
People with asthma and healthcare professionals provide strong support for mHealth for 
asthma self-management. 
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ABSTRACT  
Rationale: mHealth has the potential to revolutionise the self-management of long-term 
medical conditions such as asthma. A user-centred design is integral if mHealth is to be 
embraced by patients and healthcare professionals. Objective: Determine the perspectives of 
individuals with asthma and healthcare professionals on the use of mHealth for asthma self-
management. Methods: A sequential exploratory mixed methods design was used; focus 
groups informed the development of questionnaires, which were disseminated to individuals 
with asthma and healthcare professionals. Results: Focus group participants (18 asthma 
patients and five healthcare professionals) identified 12 potential uses of mHealth. 
Questionnaire results showed that individuals with asthma (n=186) most frequently 
requested a mHealth system to monitor asthma over time (72%) and to collect data to present 
to healthcare teams (70%). In contrast, a system alerting patients to deteriorating asthma 
control (86%) and advising them when to seek medical attention (87%) was most frequently 
selected by healthcare professionals (n=63). Individuals with asthma were less likely than 
healthcare professionals (P<0.001) to believe that assessing medication adherence and 
inhaler technique could improve asthma control. Conclusion: Our data provide strong 
support for mHealth for asthma self-management, but highlight fundamental differences 
between the perspectives of patients and healthcare professionals.  
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INTRODUCTION 
Asthma affects approximately 300 million people worldwide [1]. In many cases asthma 
control remains suboptimal and avoidable deaths are still occurring [2]. Asthma self-
management has beneficial health outcomes such as reduced hospital admissions, better lung 
function, fewer asthma symptoms and less use of rescue medication [3-6]. Asthma guidelines 
recommend that all people with asthma receive education on asthma self-management [7, 8]. 
Traditional asthma self-management programs utilise personal asthma action plans, which 
involve the monitoring of symptoms and/or peak flow, with a written action plan detailing 
how to recognise and respond to worsening asthma. This ‘pen and paper’ approach is 
burdensome and time consuming and neither patients nor healthcare teams are enthusiastic 
about their use [9]. Furthermore, action points based on rudimentary data, such as symptoms 
and peak flow, may be less effective than action points based on multiple personalised 
parameters [10]. Despite important benefits of self-management, only 27% of adults with 
asthma receive an asthma action plan [11] and patients’ adherence to written action plans is 
poor [12].   
Web-based systems offer less burdensome self-management support, which may improve 
asthma outcomes [13]. Nowadays, smartphones have become an integral part of life and 
mobile healthcare (mHealth) systems are promising tools that may revolutionise asthma self-
management. There are over 200 mobile phone applications for asthma [14] and 
supplementary wearable and inhaler based devices are widely available [15]. Currently, 
however, the utility of mHealth for asthma self-management is unknown and a recent 
Cochrane review was unable to advise clinicians and the general public on their efficacy [16]. 
Investigations into successful mHealth systems point to user-centred design practices [17]. In 
terms of asthma-self management however, there is little evidence of user-centred design 
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practices and no data exploring the perspectives of both end-users (i.e., patients and 
healthcare professionals).  
The current investigation is part of the myAirCoach project, supported by the European 
Union’s Horizon 2020 Framework Program for Research and Innovation. This project aims to 
create a user-centred mHealth tool to support the self-management of asthma. Understanding 
patients’ and healthcare professionals’ perspectives is a fundamental step in the development 
of user-centred mHealth systems. Therefore, the present study was conducted to determine 
the perspectives of individuals with asthma and healthcare professionals on the use of 
mHealth systems to support asthma self-management. Specifically, we aimed to determine 
end-user: i) experiences and perceived uses of mHealth systems for asthma self-management; 
ii) views of what measurements would be useful in managing asthma; and iii) perspectives on 
the acceptability of and barriers to using mHealth systems for asthma self-management.  
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METHODS 
Study design  
We employed a sequential exploratory mixed methods design [18], in which qualitative 
exploration (using focus groups) informed instrument development for a subsequent 
electronic questionnaire, with findings from both data sources integrated. 
  
Focus groups  
One moderator guided each focus group, following the approach from Greenbaum [19], 
according to a structured schedule of topics (table 1); the content of which was determined 
via consultation with the myAirCoach collaborators (www.myaircoach.eu) and a patient 
advisory group. Three focus groups were conducted with individuals with asthma, in 
Manchester (UK), London (UK) and Leiden (the Netherlands), and one focus group was 
conducted with healthcare professionals in Manchester (UK). The focus groups were video-
recorded, transcribed, translated where appropriate and underwent Framework Analysis 
[20]. Data were grouped under emergent themes and integrated into three pre-determined 
core categories, relating to the research aims. Data management was supported by NVivo 
qualitative analysis software (Version 10).  
Individuals aged ≥ 18 years who were patients with doctor-diagnosed asthma or a healthcare 
professional involved in the treatment of asthma were eligible to participate in the focus 
groups. Patients were recruited from respiratory clinics in Manchester and Leiden, and via 
advertisements placed online at Asthma UK’s website. Healthcare professionals were 
recruited from hospital respiratory departments in Manchester.  
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Table 1. Focus group topic guide for people with asthma and healthcare professionals  
 
Topic 1. Experiences and perceived uses of mHealth for asthma 
− Example prompts: Have you previously used mHealth systems to help manage 
your/your patients’ asthma? What would you consider would be a useful purpose of a 
mHealth system with regards to your/your patients’ asthma? 
Topic 2. Potential useful measurements for mHealth 
− Example prompts: What physiological, behavioural and environmental measurements 
could help you manage your/your patients’ asthma? 
Topic 3. Burden and barriers of mHealth 
− Example prompts: What would prevent you from using mHealth systems? 
Topic 4. Alerts and reminders 
− Example prompts: Is there any part of your/your patients’ asthma management that is 
often forgotten?  
Topic 5. User feedback and support 
− Example prompts: What type of support would you like? Examples include; intuitive 
interfaces with information about asthma, FAQs, access to GP, specialist asthma nurse, 
speak to other users 
Topic 6. Privacy 
− Example prompts: How would you feel about personal medical data being stored on a 
mobile device / being data shared with your healthcare team and/or medical 
researchers? 
Topic 7. Product design 
− Example prompts: What design aspects would you accept/find unacceptable? Would 
you consider carrying an additional device(s)?  
 
Questionnaires 
A long-list of questions was generated following analysis of the focus group transcripts. The 
clinical research team and members of the hospital’s patient and public involvement team 
(including a patient representative) assessed the questions for face validity and bias. The 
importance of each question was then ranked and the number of items reduced to generate a 
20-item questionnaire for people with asthma and 10-item questionnaire for healthcare 
professionals. The questionnaires were different for people with asthma and healthcare 
professionals, but contained some identical questions to allow comparisons between groups. 
As mHealth systems may provide multiple functions relevant to patients and healthcare 
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professionals, we did not impose any restrictions on the number of responses that could be 
selected by participants and all responses were given equal weighting. 
Individuals with asthma and healthcare professionals completed the questionnaires via an 
online survey platform (www.surveymonkey.com), over a two-week period in December 
2015.  A hyperlink to the online survey was included on adverts placed online at Asthma UK 
and the European Commission websites and via Asthma UK’s and European Federation of 
Allergy and Airways Diseases Patients’ Associations (EFA) social media channels. Healthcare 
professionals from the North West Severe Asthma Network and the North West respiratory 
postgraduate contact list were invited via e-mail to complete the online questionnaire. For 
purposes of characterising the sample, individuals with asthma completed the Asthma Control 
Questionnaire (ACQ); a score of ≥1.5 defined uncontrolled asthma and <1.5 was classified as 
controlled or partly controlled asthma [21]. Chi-square tests identified differences in response 
frequency between individuals with asthma and healthcare professionals and between 
individuals with controlled (including partly-controlled) and uncontrolled asthma, using a 
statistical software package (SPSS, version 22.0). Significance was set at P<0.05.  
Data integration  
Qualitative focus group data and quantitative results from the questionnaires were integrated 
under three core categories. Focus group quotes relating to questionnaire data were 
identified and used to illuminate and complement and/or contrast the quantitative results.  
Ethics 
An NHS research ethics committee (15/EM/0360) and the ethics committee of Leiden 
University Medical Centre (P15.195) approved this study and participants gave informed 
consent.    
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RESULTS 
Participant characteristics 
Eighteen individuals with asthma (nine females) and five healthcare professionals (two 
medical doctors, two asthma nurses and a physiologist) participated in the focus groups.  One 
hundred and eighty-six individuals with asthma completed the questionnaire; mean ± SD age 
40 ± 16 years, 135 females, and 91 with uncontrolled asthma. Sixty-three healthcare 
professionals completed the questionnaire, including 31 general practitioners, 13 hospital 
doctors, eight asthma nurses, and 11 from other healthcare disciplines.  
 
Core category 1: Experiences and perceived uses of mHealth for asthma self-management 
The experiences of individuals with asthma of using mHealth varied considerably, with some 
participants reporting no experience of using mHealth for their asthma and a few participants 
reporting considerable experience with multiple devices. Healthcare professionals’ 
experiences with mHealth systems were limited to their use during research projects. The 
types of mHealth systems that participants had experience with are presented in table 2. 
Page 13 of 33 European Respiratory Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9 
Table 2. Emergent themes identified in focus groups with people with asthma (n=18) and healthcare professionals (n=5) integrated under core 
categories 
 Emergent themes 
 
Core category 1  
Experience of mHealth  Experience with applications for: nutrition analysis, inhaler (medication) monitoring, activity level monitoring, 
lung function (peak flow) monitoring, mental health, environmental monitoring (e.g., pollution and pollen), and 
asthma diary.  
Potential uses of 
mHealth  
Replace check-ups, advise when to seek medical attention, monitor asthma over time, collect data to present to 
healthcare team, alerts to deterioration in asthma control, use as an asthma action plan, provide education 
materials, instructions on how to manage an asthma attack, a system to call for emergency help, a system to update 
medical records, a system to record side-effects and a system to determine medication effectiveness.  
Core category 2  
Useful measurements  Environment conditions (e.g., pollution, allergens (pollen), temp), lung function (e.g., peak flow and measurements 
of airway inflammation), breathing (e.g., breathing rate and details of how often you cough), heart rate and activity 
levels, stress level, medication adherence, inhaler technique, diet, quality of sleep, self-reported symptoms.  
Useful alerts  Medication running low, using their medication too much, they have not taken their inhaler, they are using their 
inhaler incorrectly, lung function is getting worse, pollution level in their area is high, pollen/ allergen levels in 
their area are high, temperature/ humidity in their area is high/ low 
Core category 3  
Acceptability and 
barriers  
Usability, product design, privacy, time, personalisability, human contact, data usefulness (e.g., reliability, 
interpretation and subjectivity), cost, mobile compatibility, medication compatibility.  
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Focus group participants identified twelve potential uses of mHealth systems for asthma self-
management (table 2). These proposed uses were developed into an item on each 
questionnaire relating to: i) functions individuals with asthma would like from mHealth; and 
ii) functions that healthcare professionals believed would be useful (table 3).  
Patients most frequently requested an mHealth system to monitor asthma over time (72%) 
and to collect data to present to healthcare teams (70%), table 3. This may relate to difficulties 
that patients have recalling symptoms and conveying these to their healthcare teams, as 
illustrated by quote 1.1 (table 4). Discussions with healthcare professionals revealed that if a 
patient presented them with data on an mHealth system that they would find this useful and 
one healthcare professional suggested that it might empower their patients, quote 1.2 (table 
4).  
Functions alerting patients to deteriorating asthma control (86%) and advising when to seek 
medical attention (87%) were most frequently selected by healthcare professionals (table 3). 
Focus group data highlighted that mHealth could prompt patients to seek medical attention 
sooner, quote 1.3 (table 4). Support for these functions amongst individuals with asthma was 
also high (table 3) and comments in the focus group discussions were broadly aligned with 
those of the healthcare professionals, quotes 1.4 and 1.5 (table 4). 
A recurring theme in the focus group discussions was the potential to incorporate asthma 
action plans into mHealth. The preference of mHealth over the traditional ‘pen and paper’ 
approach may be linked to the increased convenience/accessibility of mHealth, quote 1.6 
(table 4). In the questionnaires, 46% of patients and 79% of healthcare professionals 
(P<0.001) answered that they would like or find it useful to have an asthma action plan 
incorporated into a mHealth system. The reason behind the greater support from healthcare 
professionals was not apparent in the focus group discussions.  
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Some of the proposed uses for mHealth systems that originated in the focus group discussions 
received less support from the questionnaires. In the focus groups several patients voiced 
frustrations about attending routine asthma check-ups and proposed mHealth as a possible 
replacement, quote 1.7. However, in the surveys only 25% of patients and 33% of healthcare 
professionals indicated that they would like or find it useful for a mHealth system to replace 
routine asthma check-ups.    
Page 16 of 33European Respiratory Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
12 
Table 3. Questionnaire results: what individuals with asthma would like from a mHealth system and what healthcare professionals believe 
would be useful functions 
Response options  Asthma 
(%) 
HCPs 
(%) 
P Asthma P 
Uncontrolled  
(%) 
Controlled   
(%) 
A device/ system that could replace routine (e.g., annual) asthma check-ups 25 33 0.21 12 40 <0.001 
A device/system that offers advice regarding when additional medical attention 
should be sought  
49 87  <0.001 56 44 0.12 
A device/ system to help patients monitor their asthma over time  72 81 0.14 77 66 0.12 
A device/ system to collect data that patients can show their doctor/healthcare 
professional, to demonstrate how their asthma has been 
70 78 0.30 71 67 0.57 
A device/ system that detects and alerts patients and/or healthcare professionals 
to a deterioration in their asthma control before they would normally notice 
69 86  0.01 75 64 0.18 
A device/ system for patients to use as their asthma action plan  46 79 <0.001 53 40 0.08 
A device/ system to offer educational materials about asthma 22 73 <0.001 25 17 0.21 
A device/ system that provides instructions on how to manage their asthma in an 
emergency 
45 81 <0.001 47 44 0.68 
A device/ system that can be used to call for emergency help during an asthma 
attack 
49 52 0.69 52 49 0.71 
A device/ system that can take measurements and update a patient’s medical 
record 
53 51 0.80 56 49 0.34 
A device/system to record treatment side-effects 44 37 0.29 46 44 0.79 
A device/ system that can tell if changes to patient’s asthma medication has 
improved their asthma control 
36 76 <0.001 45 28 0.02 
Asthma, people with asthma (n=186); HCPs, healthcare professionals (n=63); Uncontrolled, individuals with an asthma control questionnaire 
(ACQ) score ≥ 1.5 (n=91); Controlled, individuals with ACQ score <1.5 (n=86).  
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Table 4. Selection of supporting quotes  
Quote No Selected quotes 
 Core category 1 
1.1  “It would be handy having an app so that you can monitor (asthma) yourself… to show your consultant and respiratory nurse exactly how your asthma 
has been… because often when they ask you can’t remember”. [Patient #7, London]  
1.2 “It's a very powerful tool to be able to show (patients) the data and say this is what is happening… rather than just saying you've got to keep taking your 
medication... you are empowering them with their treatment”. [HCP #3]  
1.3 “A little bit of a prompt to say that at these levels maybe you should be seeking medical attention, this would be helpful because then they may attend the 
accident and emergency department a little bit sooner”. [HCP #2]  
1.4 “Things sometimes get worse and I don’t necessarily notice them and, therefore, I let them get worse. It would be nice if I could monitor it and see trends 
in different things and address them” [Patient #4, London] 
1.5 “I have had that moment, where you think at what point do I call an ambulance... I would like to be able to hit a button and it says this is what you should 
be doing” [Patient #3, London] 
1.6 “If you could have your asthma check-up and plug in your asthma action plan values into something... that’s a much better way of helping people stay in 
control than a piece of paper, that when they come back from the doctors they put down and don't touch again until the next asthma check” [Patient #3, 
Manchester] 
1.7 “I really dislike going to my asthma check-up when I am pretty sure it is fairly well controlled anyway…. I go and they tell me what I already know… it 
would be nice if a device could feedback to the nurse and they could let me know when I should get a check-up”. [Patient #2, London] 
 Core category 2 
2.1 “My peak flow tends to go down and then I get worse… even if I don’t feel bad, my peak flow will be lower than it should be” [Patient #7, London]  
2.2 “On the written asthma action plans, it says if my peak flow drops below ‘X’ then I should do this with my medication... so it is useful for that” [Patient #3, 
London] 
2.3 “If it’s going to be a high pollen count, I will arrange to go out in the evening or very early in the morning and avoid that part of the day... air quality is 
something that’s a bit more difficult to avoid, but it’s useful to know and may influence whether I go for a run today or whether I wait until tomorrow” 
[Patient #4, Manchester] 
2.4 “The amount of times I rush through it [taking my inhaler]… I don’t feel like I am getting the benefit from it” [Patient #4, London] 
2.5 “Patients are on step four or five treatment but can't take an inhaler correctly… it is frightening that they are being referred to us for more invasive 
treatments” [HCP #1] 
 Core category 3 
3.1 “Not all of the asthmatic patients have the same symptoms…  I think you need to individualise the symptoms and what is measured to every patient 
separately” [HCP #5] 
3.2 “I don’t want to measure all those things… if it is one or maybe two things I might, or if you could personalise it to what is relevant to you, but I’m not 
going to measure all of those things” [Patient #2, London] 
3.3 “If it is automatically on your inhaler and it measures and gives you feedback, perfect… if I have to get a separate device out to measure it, then I would 
probably use it less” [Patient #7, Leiden] 
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3.4 “I just don’t like subjective questions. I don’t remember how bad ‘bad’ was last time I selected bad” [Patient #2, London] 
3.5 “If something is wearable and discreet, I would definitely go for something like that. If it is bulky and very visible, then maybe not” [Patient #4, London] 
HCP, healthcare professional
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Core category 2: Useful measurements for managing asthma 
The focus group discussions highlighted many measurements that participants believed could 
provide support for the self-management of asthma (table 2); these were developed into 
items on the questionnaires (table 5).  
Lung function measurements (71%) were commonly identified as being helpful to maintain 
asthma control (tables 5). This was linked with patients’ perception of a connection between 
asthma control and lung function and when to take appropriate action, quotes 2.1 & 2.2 (table 
4). Additional physiological parameters identified as being useful for asthma control included: 
resting heart rate, breathing rate, stress levels, sleep quality and diet. These measurements 
were given varying, but usually modest, support from the questionnaire data (table 5).  
Measurements regarding environmental conditions were believed to be helpful for asthma 
self-management by 71% of individuals with asthma and 68% of healthcare professionals 
(table 5). Focus group data suggest that environmental alerts may affect individuals’ 
behaviours, quote 2.3 (table 4). 
Both individuals with asthma and healthcare professionals identified the negative impact of 
incorrect inhaler technique and provided support for their integration into mHealth, quotes 
2.4 & 2.5 (table 4). However, survey data highlighted a notable contrast in the results, with a 
significantly higher proportion of healthcare professionals compared with patients believing 
measuring inhaler technique (87% vs. 43%, P<0.001) and medication adherence (89%, vs. 
48%, P<0.001) would be helpful for asthma control. 
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Table 5. Questionnaire results: Which of the following measurements do you think could help you/your patients achieve better asthma control? 
Response options  Asthma 
(%) 
HCPs 
(%) 
P Asthma P 
Uncontrolled 
(%) 
Controlled 
(%) 
Measurements of environment conditions (e.g., pollution, allergens, 
temperature and humidity) 
70 68 0.81 75 65 0.16 
Measurements of lung function (e.g., peak flow and measurements of 
airway inflammation)  
71 75 0.58 71 70 0.82 
Measurements of breathing (e.g., breathing rate and details of how 
often you cough) 
64 60 0.60 68 60 0.29 
Measurements of heart rate and activity levels 46 37 0.18 49 43 0.39 
Measurements of stress levels 53 37 0.03 57 49 0.27 
Measurements of medication adherence  48 89 <0.001 52 44 0.32 
Measurements of inhaler technique  42 87 <0.001 43 43 0.98 
Measurements of diet 32 32 0.94 36 24 0.09 
Measurements of quality of sleep 54 44 0.20 58 48 0.16 
Measurements of self-reported symptoms 34 57 <0.001 40 30 0.19 
Asthma, people with asthma (n=186); HCPs, healthcare professionals (n=63); Uncontrolled, individuals with an asthma control questionnaire 
(ACQ) score ≥ 1.5 (n=91); Controlled, individuals with ACQ score <1.5 (n=86).    
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Core category 3: Acceptability of and barriers to using mHealth systems for asthma self-
management 
Table 2 summarises perspectives on the acceptability of and barriers to the use of mHealth 
systems. The ability to personalise mHealth systems was a consistent subcategory across all 
focus groups. Discussions highlighted that different populations, e.g., children, the elderly and 
people with differing asthma severity, have different user-requirements. Furthermore, it was 
proposed that mHealth systems may need to be personalised at an individual level, quote 3.1 
(table 4). One participant with asthma suggested that measuring numerous ‘irrelevant’ 
parameters might discourage their compliance with mHealth, quote 3.2 (table 4). Similarly, 
patients highlighted that if the burden of inputting data was too much then they would not be 
willing to comply with the device and emphasised that mHealth should be as automated as 
possible, quote 3.3 (table 4).  
The topic of data usefulness was common across all focus groups and included comments 
regarding the reliability of data, data subjectivity and the interpretation of data. Individuals 
with asthma highlighted concerns with subjective measurements, such as self-reported 
symptoms, quote 3.4 (table 4). The interpretation of the data, either by automated systems or 
by the individuals themselves, was highlighted as a source of possible error and an important 
consideration. Consequently, only 12% of patients responding to the questionnaire indicated 
that they would accept all recommendations to change their medication based on feedback 
from mHealth. This value increased to 30% if data supporting the recommendation was also 
presented to the patient and to 41% if the patient’s doctor endorsed the mHealth system. 
Similarly, only 21% of healthcare professionals would be comfortable for their patients to 
change their medication based on mHealth feedback. This value increased to 46% if the 
healthcare professional could see patient data and approve the changes. Furthermore, 22% of 
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healthcare professionals would like to see the patient in person before they recommended 
any changes to their medication.  
Data security and data use was a common theme across focus groups. Patients expressed 
opposing views with regards to data security, with some patients unconcerned with how their 
data was managed and some insistent that data security is of upmost importance. Participants 
of the focus groups expressed unanimous support for their data to be used in an anonymous 
format for research purposes, whilst questionnaire results suggest just over half (58%) of 
patients were happy for anonymous data to be used for research purposes.  
Physical properties relating to product design and compatibility were discussed as important 
considerations for mHealth. Questionnaire analysis revealed that 76% of individuals with 
asthma would be willing to carry or wear at least one additional device and 72% would be 
willing to keep an additional device at home. However, discussions in the focus groups 
indicate that this might depend on the product design, quote 3.5 (table 4). 
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DISCUSSION 
The era of mHealth offers huge potential to enhance conventional healthcare. Asthma is an 
ideal candidate condition for mHealth developments, being a long-term condition that 
requires continuous attention from both healthcare professionals and patients. If mHealth 
systems are to be utilised in routine practice, they would need to be embraced by both end-
users. This is the first study to comprehensively explore patients’ and healthcare 
professionals’ perspectives on the use of mHealth for the self-management of asthma. There 
were significant differences in opinions with regards to expectations between healthcare 
professionals and patients, however both end-users provide substantial support for mHealth 
for asthma self-management.   
All people with asthma should receive a personal asthma action plan, as part of their asthma 
self-management strategy [7, 8]. However, only around a quarter of individuals with asthma 
receive such a plan [2, 11]. Our findings suggest that a large proportion of healthcare 
professionals believe that incorporating a personal asthma action plan into a mHealth system 
would be a useful function. This sentiment was commonly shared by individuals with asthma 
and vividly portrayed in the qualitative data, with one participant recalling the feeling of 
distress and indecision about how to treat their asthma and at what point to seek emergency 
attention. Neither patients nor healthcare professionals are enthusiastic about using written 
asthma action plans [9] and our data suggest the convenience of mHealth makes it an 
appealing alternative. 
An accurate initial assessment and on-going review of patients’ asthma severity and control is 
crucial for the appropriate management of the disease [2]. Our data suggest that people find it 
difficult to express asthma severity and control to their healthcare teams, and indeed it is 
known that patients often underestimate their asthma severity [22, 23]. Such discrepancies 
between perception and objective asthma severity could have drastic consequences in the 
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management of the disease. The UK National Review of Asthma Deaths (NRAD) suggests that 
poor recognition of asthma severity by patients and their healthcare teams, and subsequent 
long-term under-treatment, are avoidable factors related to asthma deaths [2]. One proposed 
use of mHealth that was well supported by both end-users, was a system that collects data 
over time, to assist patients in demonstrating their asthma control/severity to their 
healthcare teams. The selection of which parameters would be useful for this purpose merits 
careful consideration.  
We identified a variety of physiological, environmental and behavioural measurements that 
individuals with asthma and healthcare professionals believe could support asthma self-
management. Individuals with asthma most commonly responded that measurements of lung 
function would be useful for maintaining asthma control. The success of traditional asthma 
self-management programs, relying on regular peak flow measurements [5], would support 
their belief. Other physiological parameters that were identified as being useful included 
measurements of heart rate, respiratory rate and sleep quality. Given that heart rate 
variability may be associated with asthma control [24], that respiratory rate variability during 
sleep may differ between individuals with and without asthma [25], and that nocturnal 
wakening is a common complaint of individuals with asthma, the potential for these 
measurements to provide support for asthma self-management warrants further 
investigation.  
Each year 5.5 million deaths can be attributed to poor air quality [26], whilst air pollution 
exposure is associated with increased frequency of asthma attacks in children and adults [27]. 
A large proportion of individuals with asthma and healthcare professionals responding to our 
survey believe measurements of environmental conditions could help achieve better asthma 
control and should be incorporated into mHealth. 
Asthma is no longer seen as a single disease, but a syndrome with heterogeneous presentation 
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and numerous phenotypes and endotypes [28]. Participants identified that the complex and 
heterogeneous nature of asthma means that individuals will have differing requirements from 
mHealth. Whilst it is unrealistic to expect healthcare professionals to be trained in the use of 
multiple different mHealth systems, it was proposed by our participants that patients and 
their healthcare teams should be able to customise a panel of relevant functions and 
parameters for each patient. This poses a complex and challenging problem for mHealth 
developers, who should work in close partnership with a range of patients, with different 
levels of asthma control, and with healthcare professionals to ensure all end-user 
requirements are met. 
Sharp contrasts were noted in the support for some mHealth functions between patients and 
healthcare professionals. Intriguingly, the functions that received less support from patients 
appear to relate to aspects that patients may be inherently aware of and therefore see no need 
for mHealth feedback; e.g., measurements of medication adherence, inhaler technique and 
self-reported symptoms. On the contrary, the well-supported functions relate to aspects 
whereby the patient would be somewhat blind to the information without such feedback e.g., 
environmental and lung function measurements. It would seem a reasonable interpretation 
that patients advocate functions that relate to acquiring information that would otherwise be 
unknown to them, not simply monitoring parameters that they could already be aware of. In 
contrast, functions that include ‘big brother’ monitoring of patients, such as medication 
adherence and inhaler technique, were well supported by healthcare professionals. This is 
reasonable given that healthcare professionals need to know that medication has been taken 
as prescribed in order to assess treatment efficacy, and adherence to treatment is known to be 
variable [29].  
This research benefits from a mixed methods design, permitting themes identified in the focus 
groups to be quantified in the survey and integrated in the analysis to acquire a 
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comprehensive understanding of the perspectives of patients and healthcare professionals on 
mHealth for asthma self-management, However, several methodological limitations deserve 
consideration. Participants’ responses to the questionnaires were given equal weighting in the 
analysis. This method fails to take into account the strength of their opinions. This study may 
therefore have benefitted from the ability for participants to rank their responses in order of 
preference. This study may have also benefited from another round of focus group 
discussions, to probe further into the results from the questionnaire. The majority of the 
participants in the survey likely came from those who visit Asthma UK’s website or follow 
Asthma UK social media channels and, therefore, are likely to be more active and well-
educated in the management of their asthma. The possibility of selection bias should 
therefore be considered during the interpretation of the results.  
In conclusion, asthma is an ideal candidate for mHealth developments and recent times have 
seen a meteoric, but rather haphazard and often ill-informed [30] rise in mHealth systems for 
asthma self-management. A user-centred design of mHealth is integral for technology to meet 
end-users’ expectations and may improve adherence and health outcomes. This research 
provides overwhelming support for mHealth to assist asthma self-management, by both 
individuals with asthma and healthcare professionals, but highlights fundamental differences 
in preferred functions between the different end-users and identified numerous factors that 
would need consideration during the development of new mHealth devices. Developers of 
new mHealth systems should consider these opinions during the development of new user-
centred mHealth systems to aid the self-management of asthma. 
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